Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing

Slides:



Advertisements
Similar presentations
Marcello Arsura, Min Wu, Gail E Sonenshein  Immunity 
Advertisements

Volume 109, Issue 2, Pages (April 2002)
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Volume 11, Issue 6, Pages (June 2003)
Volume 14, Issue 3, Pages (May 2004)
Teshome Mebatsion, Matthias König, Karl-Klaus Conzelmann  Cell 
Volume 5, Issue 4, Pages (April 2004)
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 118, Issue 4, Pages (April 2000)
Volume 6, Issue 2, Pages (February 1997)
Katherine E. Sloan, Markus T. Bohnsack, Nicholas J. Watkins 
Volume 16, Issue 1, Pages (October 2004)
Volume 23, Issue 1, Pages (July 2006)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
Volume 13, Issue 3, Pages (February 2004)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Decreased Growth Inhibitory Responses of Squamous Carcinoma Cells to Interferon-γ Involve Failure to Recruit cki Proteins into cdk2 Complexes  Beth L.
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Identification and Characterization of an IκB Kinase
Ras Enhances Myc Protein Stability
Volume 132, Issue 2, Pages (January 2008)
Volume 7, Issue 6, Pages (June 2005)
The Mammalian UV Response
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 9, Issue 4, Pages (April 2002)
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 8, Issue 5, Pages (November 2001)
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock
Volume 91, Issue 5, Pages (November 1997)
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Ashton Breitkreutz, Lorrie Boucher, Mike Tyers  Current Biology 
Volume 8, Issue 1, Pages (January 1998)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Noritaka Oyama, Keiji Iwatsuki, Yoshimi Homma, Fumio Kaneko 
Volume 15, Issue 5, Pages (November 2001)
The Drosophila CLOCK Protein Undergoes Daily Rhythms in Abundance, Phosphorylation, and Interactions with the PER–TIM Complex  Choogon Lee, Kiho Bae,
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
p53 stabilization is decreased upon NFκB activation
c-Src Activates Endonuclease-Mediated mRNA Decay
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 61, Issue 6, Pages (June 2002)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 127, Issue 4, Pages (October 2004)
NF-κB1/p105 Regulates Lipopolysaccharide-Stimulated MAP Kinase Signaling by Governing the Stability and Function of the Tpl2 Kinase  Michael R. Waterfield,
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Ruth Halaban, Elaine Cheng  Journal of Investigative Dermatology 
Volume 8, Issue 6, Pages (December 2005)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Silva H Hanissian, Raif S Geha  Immunity 
Marcello Arsura, Min Wu, Gail E Sonenshein  Immunity 
Volume 49, Issue 5, Pages (March 2013)
Volume 55, Issue 2, Pages (February 1999)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Volume 12, Issue 5, Pages (November 2003)
Volume 13, Issue 3, Pages (February 2004)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 4, Issue 4, Pages (October 1999)
5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint  Giulio Donati, Suresh Peddigari,
Volume 7, Issue 6, Pages (June 2001)
Volume 8, Issue 5, Pages (November 2001)
A Smad Transcriptional Corepressor
Volume 22, Issue 3, Pages (May 2006)
Unassembled Ig Heavy Chains Do Not Cycle from BiP In Vivo but Require Light Chains to Trigger Their Release  Marc Vanhove, Young-Kwang Usherwood, Linda.
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
The Engagement of Sec61p in the ER Dislocation Process
Virus Subversion of the MHC Class I Peptide-Loading Complex
Presentation transcript:

Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing Masataka Sugimoto, Mei-Ling Kuo, Martine F Roussel, Charles J Sherr  Molecular Cell  Volume 11, Issue 2, Pages 415-424 (February 2003) DOI: 10.1016/S1097-2765(03)00057-1

Figure 1 Arf Induction and Cell Cycle Arrest in MT-Arf Cells (A) MT-Arf and NIH-3T3 cells were treated with zinc sulfate for the indicated times or exposed to 5-FU, and lysates were immunoblotted with antibodies to the proteins indicated at the left of the panel. (B) Two hours prior to lysis for protein and RNA analysis, parallel zinc-induced cell cultures were either pulsed with BrdU or metabolically labeled with [3H]-uridine. BrdU incorporation into DNA was measured by immunofluorescence (light gray bars), and the number of untreated cells in S phase (0 hr) was normalized to 100%. RNA was extracted and quantified by absorbance measurement, and radioactivity in aliquots was determined by scintillation counting (dark gray bars). Incorporation (cpm/μg RNA) into untreated cells (0 hr) was normalized to 100% (see Table 1). Molecular Cell 2003 11, 415-424DOI: (10.1016/S1097-2765(03)00057-1)

Figure 2 RNA Processing in MT-Arf Cells (A) Schematic illustrating steps in rRNA processing adapted from Eichler and Craig (1994) with cleavage steps indicated by vertical arrows. Sedimentation coefficients (S) of intermediates and mature rRNA products (filled bars) are shown, as are the locations of external (ETS) and internal (ITS) transcribed spacer sequences in the 47S precursor. (B) Extracted [3H]-uridine-labeled RNAs from cells treated with zinc for the indicated times were separated on a gel, transferred to membrane, and subjected to fluororadiography. Minor radiolabeled bands migrating between the 47S and 32S species (best visualized in lanes 4–7) represent less stable 41S and 36S intermediates. (C) Following zinc treatment (24 hr), cells were labeled for 30 min with [methyl-3H]-methionine and chased for the indicated times (min). Two thousand 3H counts per minute were loaded per lane. Brackets (MT-Arf, right) point to improperly processed intermediates. (D) Northern blot analysis of total RNA extracted from untreated (−) or zinc-treated (24 hr) (+) NIH-3T3 and MT-Arf cells. Equivalent amounts of RNA were loaded in each lane. The radiolabeled probe corresponded to tandem 5.8S-ITS2 sequences. Molecular Cell 2003 11, 415-424DOI: (10.1016/S1097-2765(03)00057-1)

Figure 3 Cell Cycle Arrest by Low Serum or Aphidicolin Does Not Inhibit rRNA Processing (A) NIH-3T3 or MT-Arf cells growing in medium containing 10% FCS (lanes 1–6) or arrested for 24 hr in medium containing 0.1% FCS (lanes 7–10) were treated with zinc for 24 hr or with 5-FU as indicated, and [3H]-uridine-labeled rRNA was analyzed (upper bracket) as in Figure 2B. Lysates from parallel cultures were separated on gels, transferred to membrane, and blotted with antibodies to p19Arf, cyclin D1, and Cdk4, as indicated at the left (lower bracket). (B) Quiescent NIH-3T3 or MT-Arf cells stimulated with serum to reenter the cell cycle synchronously were left untreated (lanes 1–6) or were treated with aphidicolin to rearrest them at the G1/S boundary (lanes 7–12). Cells were then exposed to zinc or 5-FU and incorporation of [3H]-uridine into rRNA was determined as above. (C) Nuclear run-on assays were used to measure transcription of 47S rRNA. The relative ratios of hybridization signals (47S rRNA/β-actin) for each sample provide an index of transcription rate in response to the indicated treatments (Table 1). Arf-specific exon-1β sequences were used to confirm Arf induction. Molecular Cell 2003 11, 415-424DOI: (10.1016/S1097-2765(03)00057-1)

Figure 4 Interference with rRNA Processing Is Not Mimicked by and Does Not Depend on p53, and Requires Arf Residues 2–14 (A) MEFs lacking both Arf and p53 were transduced with a control retroviral vector or with those encoding either p19Arf or p53. Lysates prepared 4 days later were assayed by immunoblotting for the indicated proteins. In the absence of p53, p19Arf was unable to induce the p53-responsive gene product, p21Cip1. By contrast, p53 induction of p21Cip1 does not depend on Arf. (B) Cells harvested as in (A) were metabolically labeled with [3H]-uridine, and radiolabeled rRNA species were separated on gels, transferred to membrane, and detected by fluororadiography. (C) NIH-3T3 cells treated with 5-FU or infected for 24 hr with the indicated retroviral vectors were studied as in (B). Arf mutants lacking amino acids 26–37 (d26-37) did not localize to nucleoli, whereas Arf (d2-14) did. (D) TKO MEFs infected with a retrovirus encoding wild-type (WT) Arf undergo arrest and remain viable, whereas those infected with the Arf (d2-14) mutant continue to proliferate. (E) At 3 days postinfection, cells were pulsed with BrdU and assayed by immunofluorescence for its incorporation into DNA. The number of BrdU-positive cells in S phase following infection with the control retroviral vector was normalized to 100%. (F) Arf-infected TKO MEFs were labeled 3 days postinfection with with [3H]-uridine, and radiolabeled rRNA species were separated on gels, transferred to membrane, and detected by fluororadiography. Molecular Cell 2003 11, 415-424DOI: (10.1016/S1097-2765(03)00057-1)

Figure 5 Arf Binds to 5.8S rRNA (A) Proliferating NIH-3T3 and MT-Arf cells were either left untreated (−) or were induced for 24 hr (+). Whole-cell lysates (10% of the total) were immunoblotted with antibodies to fibrillarin or p19Arf (lanes 1–4). The remaining lysates were divided in two and precipitated with antibodies to fibrillarin (lanes 5–8) or to p19Arf (lanes 9–12), and the immunoprecipitates were separated on denaturing gels, transferred to membrane, and blotted with the same and heterologous antibodies. The Ig symbol in lanes 9–12 indicates the position of immunoglobulin light chains detected with antibody to rabbit Ig, whereas the positions of fibrillarin (Fib.) and p19Arf are indicated at the right. (B) RNA coprecipitating with antibody precipitates prepared from cells as in (A) was 3′ end-labeled using T4 RNA ligase and [32P]pCp. Products were separated on polyacrylamide gels containing urea and detected by autoradiography of the dried slab gel. The major bands coprecipitating with anti-fibrillarin correspond to U3 snoRNA, 5.8S, and 5S rRNA, respectively (Tyc and Steitz, 1989). Only 5.8S rRNA coprecipitated with p19Arf. (C) TKO MEFs lacking endogeneous Arf, Mdm2, and p53 genes cells were infected with a control retroviral vector (Ctl) or vectors encoding either wild-type p19Arf (WT) or the p19Arf (d2-14) mutant. Cell lysates were prepared 3 days after infection, and 15% of the lysates (lanes 1–3) were taken for immunoblotting (top panel) and RNA analyses (bottom panel). The remaining lysates were divided in two and precipitated with antibodies directed to the p19Arf C terminus (anti-Arf) or with control rabbit serum (NRS Ctl). RNA extracted from immune precipitates was 3′ end-labeled and analyzed as in (B). Molecular Cell 2003 11, 415-424DOI: (10.1016/S1097-2765(03)00057-1)